Skip to main content
PRVA logo

PRVA · Privia Health Group, Inc. · Financials

Track PRVA — free
Market Cap
$3.14B
Shares
127.77M
Volume · Nov 16 706.65K Avg daily vol (3M) 1.26M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$2.12B +22.3%
FY2025 Revenue FY2019–FY2025
Net Income
$22.92M +59.3%
FY2025 Net Income FY2019–FY2025
Operating Margin
1.61% +0.6pp
FY2025 Operating Margin FY2019–FY2025
Diluted EPS
$0.18 +63.6%
FY2025 Diluted EPS FY2019–FY2025
Operating Cash Flow
$163.4M +49.5%
FY2025 Operating Cash Flow FY2019–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
$2.43B $2.12B $1.74B $1.66B $1.36B $966.22M $817.08M $786.36M
— — — $8.37M $542K -$1.07M -$1.92M -$6.91M
$32.53M $27.14M $26.45M $24.73M $19.74M $22.75M $11.34M $9.16M
$144.85M $138.15M $126.16M $109.59M $129.59M $255.88M $44.02M $41.83M
$12.23M $9.17M $6.16M $5.36M $3.35M $1.31M $642K $643K
$12.8M $9.91M $7.27M $6.53M $4.57M $2.46M $1.84M $1.43M
$2.38B $2.09B $1.72B $1.64B $1.38B $1.18B $791.7M $770.3M
$51.01M $34.24M $16.98M $20.65M -$19.12M -$217.44M $25.38M $16.06M
— 1.61% 0.98% 1.25% -1.41% -22.5% 3.11% 2.04%
$63.81M $44.14M $24.25M $27.18M -$14.55M -$214.97M $27.22M $17.49M
— — — — $500K $1.1M $1.9M $4M
— $9.7M $10.89M $8.37M $542K — — —
$61.7M $43.94M $27.87M $29.02M -$18.58M -$218.51M $23.46M $9.15M
$23.07M $14.21M $10.83M $7.99M -$6.52M -$27.86M -$7.44M $1.21M
$32.32M $22.92M $14.39M $23.08M -$8.59M -$188.23M $31.24M $8.24M
— 1.08% 0.83% 1.39% -0.63% -19.48% 3.82% 1.05%
$3.87M $6.81M $2.66M -$2.05M -$3.48M -$2.42M -$340K -$299K
USD/shares $0.28 $0.19 $0.12 $0.20 -$0.08 -$1.83 $0.33 $0.09
USD/shares $0.27 $0.18 $0.11 $0.19 -$0.08 -$1.83 $0.33 $0.09
shares — 122.18M 119.4M 116.73M 110.7M 102.95M 95.95M 95.93M
shares — 128.89M 125.61M 124.69M 110.7M 102.95M 95.95M 95.93M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current operating lease liabilities 2026-09-30 USD 2,107,000 10-Q filed 2026-11-05
Noncurrent operating lease liabilities 2026-09-30 USD 6,149,000 10-Q filed 2026-11-05
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
1 filing has incomplete source or extraction coverage. Verified observations are shown; missing observations do not establish that debt was unchanged.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
1.11×
Peer median 5.10×
EV/EBIT
52.74×
Peer median 30.04×
P/E (TTM)
90.93×
Peer median 43.76×
Price/Sales (TTM)
1.29×
Peer median 4.04×
Price/Book
3.85×
Peer median 3.25×
EV/Adj. EBITDA (FY2025)
21.43×
Peer median 14.22×

Peer medians compare against the 20 similar-size Health Information Services companies (of 51 listed).

EV/Adj. EBITDA uses the company-stated “Adjusted EBITDA”, extracted from the reconciliation in its SEC filings — the company's own non-GAAP definition, not an XBRL-tagged figure.

Valuation over time computed as of each quarter's filing date

EV/Adj. EBITDA uses the company-stated “Adjusted EBITDA”, extracted from the reconciliation in its SEC filings as it existed at each sample date — the company's own non-GAAP definition, not an XBRL-tagged figure. Each point's tooltip names its TTM or fiscal-year basis.

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Product & Service (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
FFS Patient Care $1,360,235,000 $1,146,156,000 $976,688,000 $869,165,000 $772,482,000 $647,314,000 $676,157,000 $572,719,000
Capitated Revenue $308,458,000 $212,987,000 $338,729,000 $218,463,000 $0 $0 — —
Shared Savings $234,815,000 $179,202,000 $170,143,000 $132,615,000 $83,016,000 $66,414,000 $39,854,000 $39,245,000
FFS Administrative Services $137,017,000 $125,431,000 $113,154,000 $94,929,000 $68,805,000 $58,278,000 $48,510,000 $32,960,000
Care Management Fee PMPM $73,138,000 $64,066,000 $50,519,000 $35,541,000 $36,503,000 $26,766,000 $18,547,000 $9,836,000
Other Revenue $9,179,000 $8,548,000 $8,504,000 $5,947,000 $5,414,000 $18,303,000 $3,292,000 $2,849,000
Administrative Service $3,500,000 $1,800,000 $2,700,000 — $0 $0 — —

Segment Operating Income

Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.

By Segment (USD)

Component FY2025 FY2024 FY2023 FY2022
Single Operating Segment $22,900,000 $14,400,000 $23,100,000 -$8,600,000
Key facts CIK 1759655 CUSIP 74276R102 13F (30d) 229 filings 213 filers Visit website Investor relations